Skip to main content
Erschienen in: European Radiology 8/2018

19.01.2018 | Gastrointestinal

Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT

verfasst von: Sun Kyung Jeon, Jeong Min Lee, Ijin Joo, Dong Ho Lee, Su Joa Ahn, Hyunsik Woo, Myoung Seok Lee, Jin-Young Jang, Joon Koo Han

Erschienen in: European Radiology | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate added value of MRI to preoperative staging MDCT for evaluation of focal liver lesions (FLLs) in potentially resectable pancreatic ductal adenocarcinomas (PDACs).

Materials and methods

In patients with potentially resectable PDACs after staging MDCT (n=167), characteristics of FLLs were scored as benign, indeterminate or metastases on an MDCT set and combined MDCT and MRI set by two readers, independently. Size of hepatic lesions was measured and detection rate of hepatic metastasis unsuspected by MDCT and diagnostic yield of MRI for FLLs were assessed.

Results

Reader-averaged figure-of-merit (FOM) of the combined set was significantly higher than that of MDCT alone (0.94 vs. 0.86, p=.028). In the negative-on-CT group, the diagnostic yield of MRI was 1.5–2.3% (2/133 and 3/133 for readers 1 and 2, respectively). In the indeterminate-on-CT group, MRI yield was 10.5–13.6% (2/19 and 3/22) and in patients with suspicious-metastasis-on-CT, 8.3–26.7% (1/12 and 4/15). All lesions with false-positive and false-negative CT findings were ≤1 cm.

Conclusion

In potentially resectable PDACs, addition of MRI with DWI can provide significantly better diagnostic performance in characterization of focal liver lesions, especially for small-sized (≤ 1 cm) MDCT-indeterminate or suspicious metastasis lesions, aiding in determination of appropriate operation candidates.

Key Points

• Addition of MRI provides better diagnostic performance in characterization of liver lesions.
• Combined interpretation of MRI and MDCT provided less frequent indeterminate liver lesions.
• Diagnostic yield of MRI was high in CT-indeterminate or suspicious metastatic lesions.
• Operation candidates can be determined with greater confidence in potentially resectable PDACs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hoos WA, James PM, Rahib L, Talley AW, Fleshman JM, Matrisian LM (2013) Pancreatic cancer clinical trials and accrual in the United States. J Clin Oncol 31:3432–3438CrossRefPubMed Hoos WA, James PM, Rahib L, Talley AW, Fleshman JM, Matrisian LM (2013) Pancreatic cancer clinical trials and accrual in the United States. J Clin Oncol 31:3432–3438CrossRefPubMed
2.
Zurück zum Zitat Al-Hawary MM, Kaza RK, Wasnik AP, Francis IR (2013) Staging of pancreatic cancer: role of imaging. Semin Roentgenol 48:245–252CrossRefPubMed Al-Hawary MM, Kaza RK, Wasnik AP, Francis IR (2013) Staging of pancreatic cancer: role of imaging. Semin Roentgenol 48:245–252CrossRefPubMed
3.
Zurück zum Zitat Disibio G, French SW (2008) Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 132:931–939PubMed Disibio G, French SW (2008) Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 132:931–939PubMed
5.
Zurück zum Zitat Gore RM, Thakrar KH, Wenzke DR, Newmark GM, Mehta UK, Berlin JW (2012) That liver lesion on MDCT in the oncology patient: is it important? Cancer Imaging 12:373–384CrossRefPubMedPubMedCentral Gore RM, Thakrar KH, Wenzke DR, Newmark GM, Mehta UK, Berlin JW (2012) That liver lesion on MDCT in the oncology patient: is it important? Cancer Imaging 12:373–384CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15:1028–1061CrossRefPubMed Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15:1028–1061CrossRefPubMed
7.
Zurück zum Zitat Elnahal SM, Shinagare AB, Szymonifka J, Hong TS, Enzinger PC, Mamon HJ (2012) Prevalence and significance of subcentimeter hepatic lesions in patients with localized pancreatic adenocarcinoma. Pract Radiat Oncol 2:e89–e94CrossRefPubMedPubMedCentral Elnahal SM, Shinagare AB, Szymonifka J, Hong TS, Enzinger PC, Mamon HJ (2012) Prevalence and significance of subcentimeter hepatic lesions in patients with localized pancreatic adenocarcinoma. Pract Radiat Oncol 2:e89–e94CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210:71–74CrossRefPubMed Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210:71–74CrossRefPubMed
10.
Zurück zum Zitat Iscanli E, Turkvatan A, Bostanci EB, Sakaogullari Z (2014) Assessment of surgical resectability of pancreatic adenocarcinomas with multidetector computed tomography: what are the possibilities and problems? Turk J Gastroenterol 25:416–423CrossRefPubMed Iscanli E, Turkvatan A, Bostanci EB, Sakaogullari Z (2014) Assessment of surgical resectability of pancreatic adenocarcinomas with multidetector computed tomography: what are the possibilities and problems? Turk J Gastroenterol 25:416–423CrossRefPubMed
11.
Zurück zum Zitat Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI (2009) Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 30:586–595CrossRefPubMed Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI (2009) Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 30:586–595CrossRefPubMed
12.
Zurück zum Zitat Motosugi U, Ichikawa T, Morisaka H et al (2011) Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 260:446–453CrossRefPubMed Motosugi U, Ichikawa T, Morisaka H et al (2011) Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 260:446–453CrossRefPubMed
13.
Zurück zum Zitat Kim HJ, Lee SS, Byun JH et al (2015) Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology 274:712–722CrossRefPubMed Kim HJ, Lee SS, Byun JH et al (2015) Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology 274:712–722CrossRefPubMed
14.
Zurück zum Zitat Vilgrain V, Esvan M, Ronot M, Caumont-Prim A, Aube C, Chatellier G (2016) A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol 26:4595–4615CrossRefPubMed Vilgrain V, Esvan M, Ronot M, Caumont-Prim A, Aube C, Chatellier G (2016) A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol 26:4595–4615CrossRefPubMed
15.
Zurück zum Zitat Kim YK, Lee MW, Lee WJ et al (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (</= 1.5 cm in diameter). Invest Radiol 47:159–166PubMed Kim YK, Lee MW, Lee WJ et al (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (</= 1.5 cm in diameter). Invest Radiol 47:159–166PubMed
16.
Zurück zum Zitat Cho JY, Lee YJ, Han HS et al (2015) Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer. World J Surg 39:1161–1166CrossRefPubMed Cho JY, Lee YJ, Han HS et al (2015) Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer. World J Surg 39:1161–1166CrossRefPubMed
17.
Zurück zum Zitat Ito T, Sugiura T, Okamura Y et al (2017) The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology 17:451–456CrossRefPubMed Ito T, Sugiura T, Okamura Y et al (2017) The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology 17:451–456CrossRefPubMed
18.
Zurück zum Zitat Kim HW, Lee JC, Paik KH et al (2017) Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. Surgery 161:1579–1587CrossRefPubMed Kim HW, Lee JC, Paik KH et al (2017) Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. Surgery 161:1579–1587CrossRefPubMed
19.
Zurück zum Zitat Chernyak V, Kim J, Rozenblit AM, Mazzoriol F, Ricci Z (2011) Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors. J Magn Reson Imaging 34:301–309CrossRefPubMed Chernyak V, Kim J, Rozenblit AM, Mazzoriol F, Ricci Z (2011) Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors. J Magn Reson Imaging 34:301–309CrossRefPubMed
20.
Zurück zum Zitat Talakic E, Steiner J, Kalmar P et al (2014) Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR. Eur J Radiol 83:607–611CrossRefPubMed Talakic E, Steiner J, Kalmar P et al (2014) Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR. Eur J Radiol 83:607–611CrossRefPubMed
21.
Zurück zum Zitat Bockhorn M, Uzunoglu FG, Adham M et al (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155:977–988CrossRefPubMed Bockhorn M, Uzunoglu FG, Adham M et al (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155:977–988CrossRefPubMed
22.
Zurück zum Zitat Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474CrossRefPubMed Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474CrossRefPubMed
23.
Zurück zum Zitat He J, Page AJ, Weiss M, Wolfgang CL, Herman JM, Pawlik TM (2014) Management of borderline and locally advanced pancreatic cancer: where do we stand? World J Gastroenterol 20:2255–2266CrossRefPubMedPubMedCentral He J, Page AJ, Weiss M, Wolfgang CL, Herman JM, Pawlik TM (2014) Management of borderline and locally advanced pancreatic cancer: where do we stand? World J Gastroenterol 20:2255–2266CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Al-Hawary MM, Francis IR, Chari ST et al (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology 270:248–260CrossRefPubMed Al-Hawary MM, Francis IR, Chari ST et al (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology 270:248–260CrossRefPubMed
25.
Zurück zum Zitat Lowenthal D, Zeile M, Lim WY et al (2011) Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 21:832–840CrossRefPubMed Lowenthal D, Zeile M, Lim WY et al (2011) Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 21:832–840CrossRefPubMed
26.
Zurück zum Zitat Muhi A, Ichikawa T, Motosugi U et al (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34:326–335CrossRefPubMed Muhi A, Ichikawa T, Motosugi U et al (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34:326–335CrossRefPubMed
27.
Zurück zum Zitat Coenegrachts K, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H (2009) Comparison of respiratory-triggered T2-weighted turbo spin-echo imaging versus breath-hold T2-weighted turbo spin-echo imaging: distinguishing benign from malignant liver lesions in patients with colorectal cancer. Jbr-btr 92:195–201PubMed Coenegrachts K, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H (2009) Comparison of respiratory-triggered T2-weighted turbo spin-echo imaging versus breath-hold T2-weighted turbo spin-echo imaging: distinguishing benign from malignant liver lesions in patients with colorectal cancer. Jbr-btr 92:195–201PubMed
28.
Zurück zum Zitat Hardie AD, Naik M, Hecht EM et al (2010) Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol 20:1431–1441CrossRefPubMed Hardie AD, Naik M, Hecht EM et al (2010) Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol 20:1431–1441CrossRefPubMed
29.
Zurück zum Zitat Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y (2003) Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226:71–78CrossRefPubMed Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y (2003) Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226:71–78CrossRefPubMed
30.
Zurück zum Zitat Quinn SF, Benjamin GG (1992) Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT. Radiology 182:545–548CrossRefPubMed Quinn SF, Benjamin GG (1992) Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT. Radiology 182:545–548CrossRefPubMed
31.
Zurück zum Zitat Semelka RC, Brown ED, Ascher SM et al (1994) Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192:401–406CrossRefPubMed Semelka RC, Brown ED, Ascher SM et al (1994) Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192:401–406CrossRefPubMed
32.
Zurück zum Zitat Chakraborty DP (2005) Recent advances in observer performance methodology: jackknife free-response ROC (JAFROC). Radiat Prot Dosimetry 114:26–31CrossRefPubMed Chakraborty DP (2005) Recent advances in observer performance methodology: jackknife free-response ROC (JAFROC). Radiat Prot Dosimetry 114:26–31CrossRefPubMed
33.
Zurück zum Zitat Chakraborty DP, Berbaum KS (2004) Observer studies involving detection and localization: modeling, analysis, and validation. Med Phys 31:2313–2330CrossRefPubMed Chakraborty DP, Berbaum KS (2004) Observer studies involving detection and localization: modeling, analysis, and validation. Med Phys 31:2313–2330CrossRefPubMed
34.
Zurück zum Zitat Lee DH, Lee JM, Hur BY et al (2016) Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging. Radiology 280:782–792CrossRefPubMed Lee DH, Lee JM, Hur BY et al (2016) Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging. Radiology 280:782–792CrossRefPubMed
35.
Zurück zum Zitat Patterson SA, Khalil HI, Panicek DM (2006) MRI evaluation of small hepatic lesions in women with breast cancer. AJR Am J Roentgenol 187:307–312CrossRefPubMed Patterson SA, Khalil HI, Panicek DM (2006) MRI evaluation of small hepatic lesions in women with breast cancer. AJR Am J Roentgenol 187:307–312CrossRefPubMed
Metadaten
Titel
Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT
verfasst von
Sun Kyung Jeon
Jeong Min Lee
Ijin Joo
Dong Ho Lee
Su Joa Ahn
Hyunsik Woo
Myoung Seok Lee
Jin-Young Jang
Joon Koo Han
Publikationsdatum
19.01.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2018
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5258-1

Weitere Artikel der Ausgabe 8/2018

European Radiology 8/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.